Anti-CA19-9 Mouse Monoclonal Antibody [clone: 121SLE]

Supplier: Biotium
BNUB0025-500 BNUB0025-100
BNUB0025-500EA 511 EUR
BNUB0025-500 BNUB0025-100
Anti-CA19-9 Mouse Monoclonal Antibody [clone: 121SLE]
Antibodies
CA19-9, a carbohydrate epitope expressed on a high MW (>400 kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is excellent for staining of formalin-fixed, paraffin-embedded tissues.

  • Purified

Type: Primary
Antigen: CA19-9
Clonality: Monoclonal
Clone: 121SLE
Conjugation: Purified
Epitope:
Host: Mouse
Isotype: IgM, kappa
Reactivity: Human
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR